Source Research:
In line with growing temperature-sensitive drug product development and consumption discussed previously, cold chain tracking infrastructure in the pharmaceutical industry is expected to see steady growth across all four regions. Both warehouse monitoring and reefer telematics will see continued investment, driven by regulatory pressure, distributors seeking to service the growing portion of the industry, and companies pursuing cost savings by reducing product loss. As the chart above shows, pharmaceutical cold chain track & trace revenue will reach US$144.8 billion by 2027, up from US$72.3 billion in 2021.
©2024 Allied Business Intelligence, Inc. All Rights Reserved